Brain & CNS Cancer Market 2018 Global Analysis, Opportunities and Forecast to 2026
Mar 15, 2018
Wiseguyreports.Com adds “Brain & CNS Cancer Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2026” To Its Research Database.
Pune, India - March 15, 2018 /MarketersMedia/ —
Brain & CNS Cancer Market 2018
Wiseguyreports.Com adds “Brain & CNS Cancer Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2026” To Its Research Database.
Report Details:
This report provides in depth study of “Brain & CNS Cancer Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Brain & CNS Cancer Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Brain & CNS Cancer in 19 Major Markets
Primary brain and central nervous system (CNS) tumours (ICD-10 codes C70-C72) are a group of primary tumours arising in the brain, meninges or central nervous system. As such, this is a cluster of conditions rather than one disease per se. There are considered to be over 120 types of brain tumour including glioblastoma multiforme (GBM), meningiomas and astrocytomas.
This report provides the current incident population for Brain & CNS Cancer across 19 Major Markets (USA, France, Germany, Italy, Spain, UK, Turkey, Russia, India, Canada, Australia, Japan, China, South Korea, Argentina, Brazil, Mexico, South Africa and Saudi Arabia) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Brain & CNS Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3028445-epiomic-epidemiology-series-brain-cns-cancer-forecast-in
Main symptoms and co-morbidities for Brain & CNS Cancer include:
• Genetic susceptibility
• Family history of brain & CNS cancers
• Ionizing radiation exposure
• Non-ionizing radiation exposure (e.g. mobile phones, electromagnetic fields)
• Growth hormone deficiencies
• Epilepsy & seizures
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Brain & CNS Cancer’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the incidence of the subdivided types of Brain & CNS Cancer and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Brain and CNS Cancer’s incident population.
• Identify sub-populations within Brain & CNS Cancer which require treatment.
• Gain an understanding of the specific markets that have the largest number of Brain & CNS Cancer patients.
If you have any special requirements, please let us know and we will offer you the report as you want.
Complete Report Details@ https://www.wiseguyreports.com/reports/3028445-epiomic-epidemiology-series-brain-cns-cancer-forecast-in
Major Key Points in Table of Content:
Table of Contents
• List of Tables and Figures
• Introduction
• Cause of the Disease
• Risk Factors & Prevention
• Diagnosis of the Disease
• Variation by Geography/Ethnicity
• Disease Prognosis & Clinical Course
• Key Co-morbid Conditions Associated with the Disease
• Methodology for Quantification of Patient Numbers
• Top-Line Brain & CNS Cancer Incidence
• Location and Histopathology of Brain & CNS Cancer
o Location of Brain & CNS Cancer
o Histopathology of Neuroepithelial Brain & CNS Cancer
o Glioblastoma Multiforme and Other Types of Glial Brain & CNS Cancer
• Abbreviations and Acronyms used in the Report
• Other Black Swan Analysis Publications
• Black Swan Analysis Online Patient-Based Databases
• Patient-Based Offering
• Online Pricing Data and Platforms
• References
• Appendix
List of Tables
• Risk factors for gliomas and meningiomas
• WHO Histologic grading for CNS tumours
• Karnofsky Performance Scale (KPS) for functional assessment
• Incidence of Brain & CNS Cancer, total (000s)
• Incidence of Brain & CNS Cancer, males (000s)
• Incidence of Brain & CNS Cancer, females (000s)
• Location of Brain & CNS Cancer tumour, total (000s)
• Incidence of Neuroepithelial Brain & CNS Cancer, total (000s)
• Histopathology of neuroepithelial Brain & CNS Cancers, total (000s)
• Incidence of Glioblastoma Multiforme and other glial cell histopathologies, total (000s)
• Abbreviations and Acronyms used in the report
• USA Incidence of Brain & CNS Cancer by 5-yr age cohort, males (000s)
• USA Incidence of Brain & CNS Cancer by 5-yr age cohort, females (000s)
• France Incidence of Brain & CNS Cancer by 5-yr age cohort, males (000s)
• France Incidence of Brain & CNS Cancer by 5-yr age cohort, females (000s)
• Germany Incidence of Brain & CNS Cancer by 5-yr age cohort, males (000s)
• Germany Incidence of Brain & CNS Cancer by 5-yr age cohort, females (000s)
• Italy Incidence of Brain & CNS Cancer by 5-yr age cohort, males (000s)
• Italy Incidence of Brain & CNS Cancer by 5-yr age cohort, females (000s)
Continued….
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: 841 198 5042
For more information, please visit https://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 314926
More News
UK warned over ballooning debt costs and slower growth ahead of Budget
Higher energy prices due to the conflict in the Middle East and climate change could hit growth.
Qantas’s New York-to-Sydney ‘Project Sunrise’ Flights to Take Off in 2028
Qantas Airways said the 18-hour flights, part of its Project Sunrise program, would come months after its 22-hour direct flights from Sydney to London begin.
Trump’s Diesel Dilemma
Calls to ban U.S. exports of the fuel are dividing Republicans. The energy crisis is also dominating discussions at the United Nations.
Concerns county will not benefit from £2 bus cap
Councillor Justine Peberdy says Yeomans Travel and Sargeants Brothers have not committed to the cap.
Off sick? You need to phone your boss, back-to-work adviser says
Relying on text and email means sick workers disengaged and were less likely to work again, says Sir Charlie Mayfield.
UK and US warned to take action on spiralling debt costs by IMF
In an interview with the BBC, Kristalina Georgieva says economic shocks had pushed "debt levels up like a staircase not to heaven".
How much do you spend on a birthday present?
Do you show you care through expensive presents? Or do you consider a drink in a pub a worthy birthday gift?
How Unions Are Confronting A.I. Threats in the Workplace
The machinists union shows how workers are negotiating for a say in the ways artificial intelligence is used in their workplaces.
Trump wants AI to be rebranded as super intelligence. Will it work?
Some people close to the president have started to use the term but experts say it is unlikely to catch on.
Trump Officials Eject 750,000 From Obamacare Markets, Claiming Fraud
Vice President JD Vance said the measure would save the government $2.2 billion.
'I don't have a buoyancy aid': Living without the Bank of Mum and Dad
Three 20-somethings tell BBC News how they are navigating life without parental support.
Europe's car makers are in crisis. Will the threat of war rescue them?
Auto executives across Europe hope rearmament can help them flex their industrial muscles once more.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.